birch pollen
Sponsors
Queen's University, Academisch Medisch Centrum
Conditions
Allergic Rhinitisallergic rhinitis
birchpollen allergy
Unknown Phase
Clinical Validation of Birch Pollen in the EEU
CompletedNCT02351830
Start: 2015-01-31End: 2015-03-31Updated: 2015-04-21
A randomized, double-blind, placebo-controlled, double-dummy study to determine the safety/tolerability of a simultaneous subcutaneous treatment of BM41 and vitamin D3 in patients with moderate to severe allergic rhinitis/ rhinoconjunctivitis caused by birch pollen.
NL-OMON45256
Target: 40Updated: 2024-02-28